Cells that are about to die send a signal to an executioner protein, but sometimes, those cells can fight back and regenerate ...
The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...
Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 years (19 months) for placebo (HR=0.23; p=0.008)7-year ...
QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, patients received the agent via subcutaneous injection every three weeks ...
Detailed price information for Cartesian Therapeutics Inc (RNAC-Q) from The Globe and Mail including charting and trades.
UCSF scientists engineered old fibroblast cells to turn their genes on and off in the same way as young fibroblasts. The old ...
A new CRISPR-based approach for tuning gene expression up and down allowed identification of how other genes' expression ...
Hijacking the energy-producing organelles from immune cells seems to help tumours in mice to infiltrate lymph nodes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback